In the present study, we documented clinicopathological characteristics of PSP‐FTD compared with PSP‐RS and systematically assessed tau pathology in neocortical and subcortical regions, with attention to distribution and density, as well as its cellular characteristics. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.